Navigation Links
UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology
Date:4/18/2012

irable effects: The most common adverse reactions (greater than or equal to 10%) are dizziness, headache, diplopia, and nausea. They were usually mild to moderate in intensity. Some were dose-related and could be alleviated by reducing the dose. Incidence and severity of CNS and gastrointestinal (GI) adverse reactions usually de-creased over time. Other common adverse reactions (greater than or equal to 1% - <10%) are depression, confusional state, insomnia, balance disorder, coordination abnormal, memory impairment, cognitive disorder, somnolence, tremor, nystagmus, hypoesthesia, dysarthria, disturbance in attention, vision blurred, vertigo, tinnitus, vomiting, constipation, flatulence, dyspepsia, dry mouth, pruritus, rash, muscle spasms, gait disturbance, asthenia, fatigue, irritability, injection site pain or discomfort (specific to solution for infusion), irritation (specific to solution for infusion), fall, and skin laceration. The use of Vimpat®  is associated with dose-related increase in the PR interval. Adverse reactions associated with PR interval prolongation (e.g. atrioventricular block, syncope, bradycardia) may occur.

Refer to the European Summary of Product Characteristics for other adverse reactions and full prescribing information. Date of revision: 21st February 2012.

http://ec.europa.eu/health/documents/community-register/html/h470.htm (Accessed 5th March 2012)

Further Information

Andrea Levin, Associate Director, Communications & PR, CNS, UCB, Inc.
T 770.970.8352 / M 404.483.7329 / Andrea.levin@ucb.com

Dana Gulick, Cooney/Waters Group
T 212.886.2227 / M 917.216.6268 / dgulick@cooneywaters.com

About UCB

UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicine
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Sunpeaks Ventures Inks Sponsorship and Marketing Agreement with Major Sports Team, Clotamin To Be Sold at Walgreens Locations Throughout Oregon and Southern Washington
2. Millennium Laboratories Sponsors Physician Education on Safe Opioid Prescribing at American Academy of Pain Medicine Annual Meeting
3. Celling Biosciences Sponsors 7th Annual Stem Cell Summit
4. Parata Systems Announces Presenting Sponsorship of 2012 Independent Pharmacy Business Growth Conference
5. goBalto Sponsors Tufts CSDD Study to Benchmark the Clinical Trial Initiation Process
6. Zimmer Sponsors Winter National Senior Games
7. Boston Scientific Sponsors New Patient Portal Dedicated to Pelvic Floor Disorders
8. Emergency Nurses Association Announces Corporate Sponsors for Annual Conference
9. SuccessEHS Sponsors California Primary Care Association
10. Johnson & Johnson Announces Global Sponsorship of the 2014 FIFA World Cup Brazil™
11. Octapharma USA Sponsors International Advisory Board for Evaluating Treatment of Patients with von Willebrand Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... YORK , August 3, 2015 ... published by Persistence Market Research "Global Market Study ... to Witness Highest Growth by 2022", the ... US$15 Bn by the end of 2015 and is ... from 2015 to 2022, to account for US$23.7 ...
(Date:8/3/2015)... SPRINGS, Florida , August 3, 2015 ... development agreements between biotech companies, military surgical ... solutions & therapies with regards to severe ... positive clinical enhancements for regenerative medicine and ... recent developments, partnerships and advancements in focus ...
(Date:8/3/2015)... , Aug. 3, 2015 VWR (NASDAQ: ... services and solutions, announces the redesign of its global website, ... When visiting the new site, guests will enjoy ... colors and vivid images.  Each country site now includes: ... to Z product menu; and , the ability to ...
Breaking Medicine Technology:Global Physiotherapy Equipment Market Will Reach US$ 23.7 Billion by 2022: Persistence Market Research 2Global Physiotherapy Equipment Market Will Reach US$ 23.7 Billion by 2022: Persistence Market Research 3Global Physiotherapy Equipment Market Will Reach US$ 23.7 Billion by 2022: Persistence Market Research 4Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 2Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 3Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 4Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 5Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 6VWR's New Website Redesign Provides Improved Functionality for Customers 2
... results, SAN DIEGO, April 9, 2008 ... Meeting suggest that an all-natural dietary,supplement made from ... lower,their blood glucose numbers after a meal and ... PhD, KGK Synergize Inc.,s Scientific Director,said, "Our scientifically ...
... Calif., April 9, 2008 ,Sunesis Pharmaceuticals, Inc. (Nasdaq: ... present data on each of its clinical-stage anticancer,compounds ... Association for,Cancer Research (AACR) being held April 12-16 ... of product candidates in oncology focused on novel,pathways ...
Cached Medicine Technology:People With Diabetes May Have All-Natural Citrus Supplement To Help Lower Blood Glucose and Cholesterol Levels 2People With Diabetes May Have All-Natural Citrus Supplement To Help Lower Blood Glucose and Cholesterol Levels 3Sunesis Pharmaceuticals to Present Non-Clinical Data at the Annual Meeting of the American Association for Cancer Research 2Sunesis Pharmaceuticals to Present Non-Clinical Data at the Annual Meeting of the American Association for Cancer Research 3
(Date:8/3/2015)... ... 2015 , ... Bayer has agreed to pay $56.9 million to set up ... alleged to have suffered an arterial blood clot including stroke and heart attack. The ... Ocella, has been ongoing for well-over five years. In 2009, lawsuits filed against Bayer ...
(Date:8/3/2015)... ... August 03, 2015 , ... Novation, the nation’s ... offer pharmacogenetic lab testing and precision medicine solutions that can help pharmacists and ... Annually, more than 8.6 million adverse drug events are reported in the U.S. ...
(Date:8/3/2015)... ... August 03, 2015 , ... Social ... , AUGUST 3, 2015 – Since winning a South by Southwest® (SXSW®) Interactive ... – an organization whose mission is to develop technology for the sake of ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... it’s new program “Designing Secure Healthcare Systems” This three-day, highly interactive and ... from healthcare organizations with access to the tactics, techniques and practices required to ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... is predicted to decline by 39 percent, according to market research compiled for ... includes data from the U.S. Department of Labor, Bureau of Labor Statistics. As ...
Breaking Medicine News(10 mins):Health News:Bayer Agrees To Settle Yaz Aterial Blood Clot Lawsuits 2Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 2Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 2Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 4Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 4Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 2Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 3
... A novel research finding from the investigators of Ohio ... of combination of metals like copper with organic chemicals ... range of diseases that are caused by virus.// ... of HIV and Hepatitis C virus RNA in the ...
... of middle-aged women and is characterized by recurring discomfort ... Symptoms vary and can include a combination of mild ... and pelvic area; and an urgent and/or frequent need ... become scarred or irritated, and pinpoint bleeding may appear ...
... HIV infection among its cadres, the Border Security Force ... outpost along West Bengal's international boundary. // ... launched in collaboration with the state AIDS control society ... troopers. ,"We are setting up these condom counters ...
... household activities like cleaning the house and the backyards, ... of prehypertension in people. // ,The study ... daily lifestyle physical activity had the effect of dropping ... hypertensive to prehypertensive and from prehypertensive to normal -- ...
... discriminate between self and non-self. If not for the ... would have lost its power to fight against diseases ... system produces certain substances called antibodies, which identify the ... "bad" so that other divisions of the immune system ...
... strong and science weak, men mistook magic for medicine; now, ... for magic. ~Thomas Szasz, The Second Sin, 1973 ... regarded as a forbidden organ too delicate to tamper with. ... World War II. Military doctors, facing injury and suffering on ...
Cached Medicine News:Health News:Metal In Medicines Can Fight Diseases Effectively 2Health News:Marijuana-Derived Drug Promises Hope In Treating Bladder Infection 2Health News:Free Condom Counters For Border Security Force Cadres 2Health News:Fighting against disease as easy as eating eggs 2Health News:Statins Taken For Reducing Cholesterol Found To Reduce Death Rate Associated With Heart Attack As Well 2
... System includes: Mx3005P instrument and custom ... five (5) filters. The standard filter ... HEX/JOE/VIC (535nm-555nm), ROX/Texas Red (585nm-610nm), Cy5 ... includes notebook computer, Mx3005P analysis software, ...
... temperature cyclers, the gradient block can be set ... to 14 or 22 across the 40- or ... up to 2C between adjacent wells in each ... 12 different annealing temperatures in a single experiment. ...
... The system includes: Mx3005P instrument and ... of five (5) filters. The standard ... (492nm-516nm), HEX/JOE/VIC (535nm-555nm), ROX/Texas Red (585nm-610nm), ... included: desktop computer, Mx3005P analysis software, ...
... includes: Mx3005P instrument and custom filter ... (5) filters. The standard filter set ... (535nm-555nm), ROX/Texas Red (585nm-610nm), Cy5 (635nm-665nm) ... computer, Mx3005P analysis software, Beacon Designer ...
Medicine Products: